Grafa News and Videos — Page 320

Xanadu (NASDAQ:XNDU) and Lockheed Martin (NYSE:LMT) announced a strategic collaboration to expand internal quantum programming training.

Summit Therapeutics (NASDAQ:SMMT) sold its investigational Phase III precision antibiotic ridinilazole to Biossil for up to $105 million.

Fastenal (NASDAQ:FAST) reported second-quarter revenue of $2.39 billion and earnings per share of $0.33.

Bitcoin (CRYPTO:BTC) stabilised after falling from US$64,400 to US$61,800, trading at approximately US$62,600 as market participants assessed the impact of a sharp decline in South Korean equities.

Bank of America (NYSE:BAC) reported second-quarter earnings per share of $1.21 on $31.6 billion in total revenue.

JPMorgan Chase (NYSE:JPM) reported a second-quarter earnings per share of $7.70 on $57.35 billion in total revenue.

Wells Fargo (NYSE:WFC) reported a 17% increase in net income to $6.41 billion for the second quarter.

Spero Therapeutics (NASDAQ:SPRO) licensed SP001 from Innovent Biologics in an agreement valued at approximately US$1.1 billion.

NextCure (NASDAQ:NXTC) agreed to merge with privately held Avere Therapeutics in an all-stock transaction supported by a concurrent $320 million private placement.

Beam Global (NASDAQ:BEEM) reported preliminary Q2 2026 revenue above $8.5 million, up more than 170% sequentially and over 20% annually.